NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,127 filers reported holding NOVARTIS A G in Q2 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $345,102 | -4.6% | 3,388 | -5.5% | 0.09% | -3.1% |
Q2 2023 | $361,863 | +21.1% | 3,586 | +10.4% | 0.10% | +10.3% |
Q1 2023 | $298,908 | -37.2% | 3,249 | -38.0% | 0.09% | -40.4% |
Q4 2022 | $475,736 | +3.4% | 5,244 | -13.4% | 0.15% | -7.0% |
Q3 2022 | $460,000 | -11.0% | 6,054 | -1.1% | 0.16% | -8.7% |
Q2 2022 | $517,000 | -2.8% | 6,124 | +0.8% | 0.17% | +16.2% |
Q1 2022 | $532,000 | +97.0% | 6,074 | +96.5% | 0.15% | +111.4% |
Q4 2021 | $270,000 | -49.7% | 3,091 | -53.0% | 0.07% | -52.4% |
Q3 2021 | $537,000 | -9.0% | 6,578 | +1.7% | 0.15% | -12.0% |
Q2 2021 | $590,000 | +9.5% | 6,469 | +2.4% | 0.17% | +0.6% |
Q1 2021 | $539,000 | -13.8% | 6,315 | -4.7% | 0.17% | -16.6% |
Q4 2020 | $625,000 | +105.6% | 6,628 | +89.5% | 0.20% | +77.7% |
Q3 2020 | $304,000 | +1.3% | 3,498 | +1.8% | 0.11% | -9.7% |
Q2 2020 | $300,000 | +7.1% | 3,437 | +1.1% | 0.12% | -13.9% |
Q1 2020 | $280,000 | +16.2% | 3,398 | +33.3% | 0.14% | +56.5% |
Q4 2019 | $241,000 | – | 2,549 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EXENCIAL WEALTH ADVISORS, LLC | 188,514 | $13,713,000 | 5.95% |
PRENTISS SMITH & CO INC | 136,441 | $10,133,000 | 5.74% |
MANAGED ASSET PORTFOLIOS, LLC | 204,985 | $15,225,000 | 5.46% |
Osher Van de Voorde Investment Management | 108,725 | $8,075,000 | 4.40% |
BROWN BROTHERS HARRIMAN & CO | 10,796,684 | $801,870,000 | 4.35% |
SECTORAL ASSET MANAGEMENT INC | 472,296 | $35,077,000 | 4.10% |
PROFESSIONAL ADVISORY SERVICES INC | 235,347 | $17,479,000 | 3.87% |
Elefante Mark B | 5,619 | $417,000 | 3.78% |
SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $18,959,000 | 3.71% |
CGOV Asset Management | 997,161 | $98,662,000 | 3.61% |